Latest High-intensity focused ultrasound Stories
Popular radiofrequency treatment provides early and, long-lasting results HAYWARD, Calif., May 6, 2013 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the global market leader in aesthetic skin treatments, today announced the Thermage(®) Total Tip 3.0, a highly effective treatment tip for face and neck as well as other body treatments that offers the earliest visible results in Thermage treatment history in addition to the consistent long-term results. Targeted, uniform, bulk...
UCL's Mark Emberton, MD, to Direct Premier Training Center for the Use of Advanced Imaging Capabilities to Localize Cancer and Deliver HIFU Treatment Using Tissue Preserving Techniques CHARLOTTE, N.C., May 2, 2013 /PRNewswire/ -- SonaCare Medical, a global leader in minimally invasive HIFU technologies, announced today that it has partnered with University College London (UCL) to create a HIFU Center of Excellence. The Center of Excellence will provide physician training and...
BOTHELL, Wash., May 2, 2013 /PRNewswire/ -- Today, at the 38th Annual Regional Anesthesiology and Acute Pain Medicine Meeting (ASRA), Alpinion Medical Systems (Booth #13) introduced the lightweight, highly portable E-Cube 7 ultrasound system for use in guidance during regional anesthesia and pain medicine procedures. The launch marks Alpinion's emergence into the U.S. market, following the company's success in the rest of the world. "With 2,000 systems installed worldwide, Alpinion...
Sonatherm is the Only Laparoscopic HIFU Device Cleared for Ablating Soft Tissue in the U.S. CHARLOTTE, N.C., May 2, 2013 /PRNewswire/ -- SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced today that it will launch the FDA-Cleared Sonatherm(®) HIFU Surgical Ablation System at the the 108(th) Annual Meeting of the American Urological Association (AUA), in San Diego, May 4-8, 2013 (booth #3611). A state-of-the-art...
SmartTarget Offers a Clinically Tested and Practical Solution for MRI-Ultrasound Fusion CHARLOTTE, N.C. and LONDON, April 30, 2013 /PRNewswire/ -- SonaCare Medical, a global leader in minimally invasive High-Intensity Focused Ultrasound (HIFU) technologies, and UCL Business PLC (UCLB), a leading technology transfer company that supports and commercializes research and innovations from UCL (University College London), today announced a partnership to integrate SmartTarget image...
Microbubbles decrease the time and acoustic power of ultrasound required to heat and destroy an embedded target, finds research in BioMed Central's open access journal Journal of Therapeutic Ultrasound. If these results can be replicated in the clinic, microbubbles could improve the efficiency of high intensity ultrasound treatment of solid tumors. High intensity ultrasound is already used to treat solid tumors. Ultrasound can be focused through soft tissue and, because it does not require...
PMI initiates Transurethral Ultrasound Ablation (TULSA) clinical trial for novel, minimally invasive device for localized prostate cancer treatment TORONTO, April 25, 2013 /PRNewswire/ - Profound Medical Inc. today announced the commencement of its Health Canada approved, multi-center TULSA (Transurethral Ultrasound Ablation) clinical trial for its minimally invasive, novel ablation device used to facilitate prostate cancer treatment. In the world's first procedure of its kind, a...
LONDON, ON, April 24, 2013 /PRNewswire/ - A world first procedure performed at London Health Sciences Center (LHSC) and facilitated by research at Lawson Health Research Institute (Lawson) provides a new minimally invasive treatment option for patients with localized prostate cancer. The treatment - transurethral magnetic resonance (MR) guided ultrasound ablation for prostate cancer - utilizes a new ablation device that uses thermal ultrasound therapy with real-time MR image...
Multispectral photoacoustic imaging, which combines laser optics and ultrasound imaging technologies, can reliably distinguish between benign and malignant prostate tissue, a new study indicates. Researchers at the University of Rochester looked at 42 prostatectomy specimens using the new imaging technique. Multispectral photoacoustic imaging, still in its infancy, predicted 25 out of 26 benign tissues correctly and 13 out of 16 malignant tissues correctly, said Dr. Vikram Dogra, lead...
TIRAT CARMEL, Israel, April 18, 2013 /PRNewswire/ -- InSightec Ltd. announced today that the US Centers for Medicare & Medicaid Services (CMS), a federal agency within the US Department of Health and Human Services (HHS), has created a new billing code for MR guided focused ultrasound treatment of pain palliation of metastatic bone lesions and has established a Medicare payment rate for hospital outpatient departments. InSightec's ExAblate received Food and Drug...
